<DOC>
	<DOCNO>NCT02200627</DOCNO>
	<brief_summary>The purpose investigation confirm follow post-marketing actual use Forxiga Tablets ( hereinafter refer Forxiga ) elderly patient . - Development ADRs specify Key Investigation Items risk factor - Contributing factor possibly impact safety efficacy - Development ADRs unexpected Precautions use ADRs actual drug use</brief_summary>
	<brief_title>Forxiga Tablets Specific Clinical Experience Investigation Elderly</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Patients treat Forxiga first time three month launch due type 2 diabetes mellitus , indication drug , age 65 time Forxiga start . In addition , patient receive study drug Forxiga launch include also . N/A</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Forxiga</keyword>
	<keyword>Elderly</keyword>
</DOC>